Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Terminated

Misys Laboratory System versions 5.23 and 5.3

FDA Recall Z-0804-03 · Posted 2003-05-09

Recalling FirmMisys Healthcare Systems
Recall StatusTerminated
Date Initiated2003-03-27
Date Terminated2004-04-21
Product Quantity463

Reason for Recall

Software anomaly.

Firm Action

The firm sent notification of the situation in Product Safety Notice PSN-03-L14 by fax on 3/27/2003. It communicated a workaround solution and informed of an impending code addition intended to be made available at a future date.

Root Cause

Other

Distribution Pattern

Nationwide and to United Kingdom, Ireland, Canada, Denmark, Bermuda, Saudi Arabia, United Arab Emirates,

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.

↑